D019496Chemicals & DrugsD20.215.894.2004100.991819Cancer VaccinesFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersontrue1Associate ProfessorAssociate Professor1.090920.1177514research area of0.5282380.057351515subject area for25586468Schuster J, Lai RK, Recht LD, Reardon DA, Paleologos NA, Groves MD, Mrugala MM, Jensen R, Baehring JM, Sloan A, Archer GE, Bigner DD, Cruickshank S, Green JA, Keler T, Davis TA, Heimberger AB, Sampson JHNeuro-oncologyA phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. Neuro Oncol. 2015 Jun; 17(6):854-61.Neuro Oncol2015-01-13T00:00:002015A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.Radiation OncologyTerryLichtorTerry Lichtor349401Lichtor, TerryAssociate ProfessorStephanieCrowleyStephanie J. Crowley41.87724600000000-87.66843480000000349538Crowley, StephanieAssociate ProfessorMartaBatusMarta Batus349586Batus, MartaAssociate ProfessorRossAbramsRoss Abrams349600Abrams, RossProfessor5Associate Professor4Professor22149999Zhang RT, Bines SD, Ruby C, Kaufman HLImmunotherapyTroVax(?) vaccine therapy for renal cell carcinoma. Immunotherapy. 2012 Jan; 4(1):27-42.Immunotherapy2012-01-01T00:00:002012TroVax(?) vaccine therapy for renal cell carcinoma.21217520Lutz E, Yeo CJ, Lillemoe KD, Biedrzycki B, Kobrin B, Herman J, Sugar E, Piantadosi S, Cameron JL, Solt S, Onners B, Tartakovsky I, Choi M, Sharma R, Illei PB, Hruban RH, Abrams RA, Le D, Jaffee E, Laheru DAnnals of surgeryA lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35.Ann Surg2011-02-01T00:00:002011A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.21952277Kabaker K, Shell K, Kaufman HLCancer journal (Sudbury, Mass.)Vaccines for colorectal cancer and renal cell carcinoma. Cancer J. 2011 Sep-Oct; 17(5):283-93.Cancer J2011-09-01T00:00:002011Vaccines for colorectal cancer and renal cell carcinoma.22639166Lichtor T, Glick RPAdvances in experimental medicine and biologyImmunogene therapy. Adv Exp Med Biol. 2012; 746:151-65.Adv Exp Med Biol2012-01-01T00:00:002012Immunogene therapy.Behavioral SciencesRush University, Rush Medical CollegeInternal Medicine, Division of Hematology/Oncology/Cell TherapyNeurological Surgerytrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor